Ajer Jeffrey Robert 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Aug 17, 2023
Insider Transaction Report
Form 4
Ajer Jeffrey Robert
SVP, Chief Commercial Of
Transactions
- Award
Common Stock
2023-04-28$66.88/sh+318$21,267→ 65,804 total - Sale
Common Stock
2023-08-16$90.00/sh−5,000$450,000→ 60,804 total
Footnotes (2)
- [F1]Represents the shares acquired by the reporting person on April 28, 2023, pursuant to the issuer's Employee Stock Purchase Plan.
- [F2]Trade made pursuant to a 10b5-1 plan executed on April 13, 2023.